Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company that is developing therapies for patients suffering from serious diseases with a high unmet medical need. Its main focus is on developing voclosporin, an investigational drug, for the treatment of lupus nephritis and Dry Eye Syndrome. The company is headquartered in Victoria, British Columbia, and has a commercial hub in Rockville, MD. Aurinia focuses its development efforts globally.
Aurinia Pharmaceuticals Inc.'s ticker is AUP
The company's shares trade on the TSX stock exchange
They are based in Victoria, British Columbia
There are 201-500 employees working at Aurinia Pharmaceuticals Inc.
It is https://www.auriniapharma.com/
Aurinia Pharmaceuticals Inc. is in the Healthcare sector
Aurinia Pharmaceuticals Inc. is in the Biotechnology industry
The following five companies are Aurinia Pharmaceuticals Inc.'s industry peers: